Publicaciones en colaboración con investigadores/as de Universidad de Las Palmas de Gran Canaria (20)

2023

  1. Correction: Vitamin C and folate status in hereditary fructose intolerance (European Journal of Clinical Nutrition, (2022), 76, 12, (1733-1739), 10.1038/s41430-022-01178-3)

    European Journal of Clinical Nutrition

  2. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 307-317

2022

  1. Vitamin C and folate status in hereditary fructose intolerance

    European Journal of Clinical Nutrition, Vol. 76, Núm. 12, pp. 1733-1739

2021

  1. Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)

    Drugs

  2. Cystathionine ß-synthase deficiency in the E-HOD registry-part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis

    Journal of Inherited Metabolic Disease, Vol. 44, Núm. 3, pp. 677-692

  3. REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

    Drugs, Vol. 81, Núm. 15, pp. 1763-1774

  4. Recomendaciones de la SEIOMM en la prevención y tratamiento del déficit de vitamina D

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 2, pp. 84-97

  5. Transferrin isoforms, old but new biomarkers in hereditary fructose intolerance

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2020

  1. Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study

    European Journal of Nutrition, Vol. 59, Núm. 5, pp. 2195-2206

2019

  1. Betaine anhydrous in homocystinuria: Results from the RoCH registry

    Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1

  2. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o

  3. Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders

    Journal of pharmaceutical and biomedical analysis, Vol. 176, pp. 112798

2018

  1. Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015–2020

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 402-410

  2. Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

    PLoS ONE, Vol. 13, Núm. 6

2017

  1. First reported treatment of aggressive hemangioma with intraoperative radiation therapy and kyphoplasty (Kypho-IORT)

    Clinical and Translational Radiation Oncology, Vol. 2, pp. 19-22

  2. Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: Patient perspectives

    Patient Preference and Adherence, Vol. 11, pp. 1489-1496

2016

  1. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions

    Critical Care, Vol. 20, Núm. 1

  2. Effects of maternal omega-3 supplementation on fatty acids and on visual and cognitive development: A randomized trial

    World Review of Nutrition and Dietetics

  3. Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome

    Journal of Infection, Vol. 73, Núm. 5, pp. 419-426

2015

  1. Effects of maternal ω-3 supplementation on fatty acids and on visual and cognitive development

    Journal of Pediatric Gastroenterology and Nutrition, Vol. 61, Núm. 4, pp. 472-480